Search

Search Constraints

You searched for: Subject Fibroblasts -- Systemic Sclerosis -- Treatment

Search Results

1. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis. Issue 3 (14th January 2015)

2. Activation of pregnane X receptor inhibits experimental dermal fibrosis. Issue 4 (4th January 2013)

3. Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Issue 7 (17th April 2013)

4. Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability. Issue 6 (20th January 2014)

5. Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis. Issue 1 (25th April 2016)

6. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis. Issue 6 (9th May 2013)

7. Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling. Issue 3 (20th November 2013)

8. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis. Issue 5 (15th January 2014)

9. Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors. Issue 12 (7th September 2013)